Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tagrisso
Tagrisso
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
Clinical Trials Arena
Tue, 02/20/24 - 11:30 am
Daiichi Sankyo
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
FDA approves AstraZeneca's Tagrisso-chemo combo
Reuters
Sun, 02/18/24 - 08:26 pm
AstraZeneca
Tagrisso
lung cancer
FDA
AstraZeneca picks up a friend for Tagrisso in $40M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 pm
AstraZeneca
Allorion Therapeutics
lung cancer
Tagrisso
J&J Seeks Expanded Use of Lung Cancer Drug Rybrevant
Yahoo/Zacks.com
Wed, 11/22/23 - 11:38 am
JNJ
Rybevant
non-small cell lung cancer
AstraZeneca
Tagrisso
[podcast]AstraZeneca’s Arun Krishna says Tagrisso-based combo promises new option in lung cancer
Medical Marketing and Media
Thu, 10/26/23 - 10:37 am
AstraZeneca
Arun Krishna
Tagrisso
lung cancer
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
ESMO
non-small cell lung cancer
Roche
Alecensa
AstraZeneca
Tagrisso
JNJ
Rybrevant
Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Medical Marketing and Media
Thu, 10/19/23 - 11:29 am
JNJ
Rybrevant
AstraZeneca
Tagrisso
EGFR-mutated NSCLC
AZ’s Tagrisso plus chemo get fast FDA review for lung cancer
Pharmaphorum
Mon, 10/16/23 - 10:20 am
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
EGFR-positive non-small cell lung cancer
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
JNJ
non-small cell lung cancer
AstraZeneca
Rybrevant
lazertinib
Tagrisso
WCLC: Tagrisso's chemo combo shows edge, but AstraZeneca thinks monotherapy remains king in lung cancer
Fierce Pharma
Mon, 09/11/23 - 12:27 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
JNJ
Rybrevant
non-small cell lung cancer
Takeda
Tagrisso
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
BioSpace
Mon, 06/5/23 - 09:59 pm
ASCO 2023
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Yahoo/Reuters
Wed, 05/17/23 - 11:16 am
AstraZeneca
clinical trials
Tagrisso
Lazertinib and Tagrisso go head to head
EP Vantage
Fri, 03/24/23 - 10:01 am
AstraZeneca
lazertinib
Tagrisso
JNJ
lung cancer
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Endpoints
Thu, 03/9/23 - 10:00 am
AstraZeneca
lung cancer
clinical trials
Tagrisso
Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 08/16/22 - 12:15 pm
Genprex
clinical trials
Reqorsa
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
Endpoints
Mon, 08/8/22 - 09:54 am
AstraZeneca
Hutchmed
clinical trials
Tagrisso
savolitinib
lung cancer
AstraZeneca staves off last Tagrisso copycat with settlement—for now
Fierce Pharma
Wed, 04/27/22 - 10:40 pm
AstraZeneca
Tagrisso
patents
legal
Alembic Pharmaceuticals
generics
Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication
Endpoints
Mon, 12/21/20 - 10:59 am
AstraZeneca
Tagrisso
non-small cell lung cancer
JNJ
amivantamab
Pages
1
2
3
next ›
last »